about
Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathiesAnorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesisImproved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirinDominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophyExpression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosisLung imaging during acute chest syndrome in sickle cell disease: computed tomography patterns and diagnostic accuracy of bedside chest radiographGene expression in lungs of mice lacking the 5-hydroxytryptamine transporter gene.Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injuryPulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective.Stimulation of angiogenesis by Cyr61 gene: a new therapeutic candidate.Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease.Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease.Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis.Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats.Aging-related systemic manifestations in COPD patients and cigarette smokers.Regulation of immunoproteasome function in the lung.Genetic basis of pulmonary arterial hypertension: current understanding and future directions.Pulmonary acceleration time to optimize the timing of lung transplant in cystic fibrosis.Conflicting physiological and genomic cardiopulmonary effects of recruitment maneuvers in murine acute lung injury.Role for telomerase in pulmonary hypertensionShortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease.Senescent Cells Contribute to the Physiological Remodeling of Aged LungsRapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertensionPrevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac AmyloidosisEndothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.Cellular and molecular basis of pulmonary arterial hypertension.Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension.The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.Update in pulmonary vascular diseases 2011.Serotonin transporter and serotonin receptors.Telomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential.Short-term high-fat diet compromises myocardial function: a radial strain rate imaging study.Middle age exacerbates acute respiratory distress syndrome in a double hit murine model.Impaired Humoral and Cellular Immune Responses to Influenza Vaccination in COPD Patient.Telomere Shortening in Middle-Aged Men with Sleep-disordered Breathing.Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension.Apnea-hypopnea and desaturations in heart failure with reduced ejection fraction: Are we aiming at the right target?CCR5 as a treatment target in pulmonary arterial hypertension.
P50
Q21558546-2FBAC2F6-BC23-4F52-B1B6-D0046945F241Q24799173-B7435CC5-D5E1-418E-B487-47997CAF8440Q28195607-F8B268D2-EB24-447E-82DA-A2E3ADA01D5AQ28266103-6A83C889-5D0E-424B-A271-8917D9798B2BQ30370033-F6B824D6-E37B-4BBA-9AC3-1D24F0678CD6Q30828240-0CA2922E-C356-4B3F-94D5-D6FCE896A272Q33442097-E12778A1-DE06-4ED1-9273-984EEBD47BA3Q33582033-B1CD9F05-7B71-47FF-AE13-9D196F5BCD13Q34118964-4AAF33FC-C239-44C8-ADE0-917789A91635Q34148088-9EE63E62-3719-4693-A2A4-E797C79C66C1Q34196738-A9CBC482-8B5B-457A-8FD7-AB86B15C6B20Q34650342-DF7E8E78-20FA-42FC-9A2F-54831CC9F11CQ34733041-8BBA83EB-8A8D-42AF-A355-501F3BD18567Q34996909-7D31C740-A198-4F36-8A90-A71C42F4F6E9Q35151656-3295C827-1C67-4146-A9A9-C75D97CB066CQ35192574-CC516071-4EDD-45B9-8157-D82E03E9A507Q35623348-22A34642-F8EA-4AA1-B6F9-F283F2C513A4Q35803345-03AC5D2A-8CC9-4F6C-BD71-A39674281093Q35929774-F803FAA9-E394-45C6-BC4D-2D86922F5992Q35987325-B26736CC-B156-4552-A5DD-21EFD4202293Q36776314-750D3815-4DB7-4C85-9D4F-03C72C34588BQ36849827-87306664-0B7F-4853-BC6F-43C7369FF501Q36885316-328FD8DA-D4EB-4772-A38D-E9EED2D75505Q36990317-5B10A7C6-61E3-46A7-A974-2D7B490E4A22Q37009096-9EA2780C-0CF9-49E5-AAFD-7DA0C88EC2D9Q37111334-3E57B806-F6BC-48A3-8AE6-A7A03F82B2ABQ37465320-D459E800-6907-45E5-8167-18AA91491232Q37706842-6B43BFA1-244C-4079-A08C-2EF99AC94B60Q37728398-550B8F5C-F8F9-4576-9A1F-3F961A9D20ACQ38015787-D4CB2E3D-E060-4AAF-BCD4-32D8F0343191Q38149037-EB2B4E8F-0DC6-47D0-A578-D37B9C34FF8AQ38533808-DCE853D0-41E5-476A-95A8-982962E1C6DBQ39034935-3263C4E9-ADDB-4F97-AB74-6FDCA480589DQ39414001-7634926D-95A4-4925-ADCA-242AAD442775Q40048960-71540F1B-9615-4A83-A8D2-AEB1538141A9Q40761986-F6CDB867-F000-4724-955E-4987109F8DE8Q40855297-98BFD966-1C43-451A-BDC0-611A85AA456EQ41078543-18526203-4356-42D5-B543-0BD1D4F9EFFCQ42020850-5BE17AA8-DFE2-43BA-8AB2-5965FE6150C7
P50
description
Médecin, Universitaire
@fr
onderzoeker
@nl
name
Serge Adnot
@ast
Serge Adnot
@de
Serge Adnot
@en
Serge Adnot
@es
Serge Adnot
@fr
Serge Adnot
@it
Serge Adnot
@sl
type
label
Serge Adnot
@ast
Serge Adnot
@de
Serge Adnot
@en
Serge Adnot
@es
Serge Adnot
@fr
Serge Adnot
@it
Serge Adnot
@sl
prefLabel
Serge Adnot
@ast
Serge Adnot
@de
Serge Adnot
@en
Serge Adnot
@es
Serge Adnot
@fr
Serge Adnot
@it
Serge Adnot
@sl
P106
P21
P31
P4124
serge-adnot_67652